Austrian PBC Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Vienna

About this trial

The goal of this registry is to better understand how primary biliary cholangitis develops over time, including the role of disease-related biomarkers, complications of the disease, and symptom burden. Patients with primary biliary cholangitis treated at participating centres in Austria will be invited to take part in this prospective registry. Participation in an associated biobank is optional. Clinical and laboratory data will be collected, and patients will be followed regularly through scheduled clinic visits. In addition, biological samples (serum, plasma, and, if available, liver tissue) may be collected and stored in the biobank for future research.

Eligibility criteria

Qualifiers

Age >18 years

Confirmed diagnosis of primary biliary cholangitis (at least two of the following three criteria must be fulfilled: persistent elevation of alkaline phosphatase above the upper limit of normal for at least 6 months; presence of antimitochondrial antibodies or PBC-specific antinuclear antibodies; characteristic histopathology)

Written informed consent for participation in the registry

Disqualifiers

Withdrawal of written informed consent

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Medical University of Vienna

Lead sponsor

Klinik Ottakring

Collaborator

Medical University of Graz

Collaborator

Salzburger Universitätsklinkum

Collaborator

Universitätsklinikum St. Pölten

Collaborator

Kepler University Hospital

Collaborator

Klinikum Klagenfurt am Wörthersee

Collaborator

Klinikum Wels-Grieskirchen

Collaborator

Medical University Innsbruck

Collaborator

Ordensklinikum Linz GmbH Krankenhaus Barmherzige Schwestern

Collaborator

Krankenanstalt Rudolfstiftung

Collaborator